The mutation rates of TP53 in low-grade PanIN/IPMN, high-grade PanIN/IPMN and PDAC were 5.4%, 42.8% and 75%, respectively, which were in rough agreement with the prevalence detected in tissue samples. This evidence concerns the gene TP53 and pancreatic intraductal papillary-mucinous neoplasm.